Detalhe da pesquisa
1.
Indicated Opioids in Pregnancy: Guidance on Providing Comprehensive Care.
Am J Perinatol;
40(6): 602-611, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34768306
2.
The Association between Prenatal Nicotine Exposure and Offspring's Hearing Impairment.
Am J Perinatol;
2022 Aug 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36007918
3.
Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease.
Br J Haematol;
197(6): 795-801, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35332544
4.
Unintended consequences of the transition to telehealth for pregnancies complicated by opioid use disorder during the coronavirus disease 2019 pandemic.
Am J Obstet Gynecol;
223(5): 770-772, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32771380
5.
Trial of Intrapartum Extended-Release Nifedipine to Prevent Severe Hypertension Among Pregnant Individuals With Preeclampsia With Severe Features.
Hypertension;
80(2): 335-342, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36189646
6.
Postoperative Cesarean Pain Management and Opioid Use Disorder: Anticipate the Need for Higher Opioid Doses and Communicate Expectations With Patients and the Obstetric Team.
J Addict Med;
16(5): 495-498, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35149613
7.
Risk factors for preterm birth among gravid individuals receiving buprenorphine for opioid use disorder.
Am J Obstet Gynecol MFM;
4(3): 100582, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35123110
8.
Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider.
Am J Obstet Gynecol MFM;
3(6): 100451, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34320429
10.
Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women.
Obstet Gynecol;
136(5): 902-903, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33030872